IGSF1
Immunoglobulin superfamily member 1
Also known as: IGCD1, IGDC1, IGSF1_HUMAN, INHBP, KIAA0364, MGC75490, PGSF2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N6C5
- Gene
- IGSF1
- Ensembl
- ENSG00000147255
- Chromosome
- X
- Canonical length
- 1336 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the immunoglobulin-like domain-containing superfamily. Proteins in this superfamily contain varying numbers of immunoglobulin-like domains and are thought to participate in the regulation of interactions between cells. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
1336 residues, UniProt reviewed canonical sequence.
>Q8N6C5|IGSF1
1 MTLDRPGEGA TMLKTFTVLL FCIRMSLGMT SIVMDPQPEL WIESNYPQAP WENITLWCRS
61 PSRISSKFLL LKDKTQMTWI RPSHKTFQVS FLIGALTESN AGLYRCCYWK ETGWSKPSKV
121 LELEAPGQLP KPIFWIQAET PALPGCNVNI LCHGWLQDLV FMLFKEGYAE PVDYQVPTGT
181 MAIFSIDNLT PEDEGVYICR THIQMLPTLW SEPSNPLKLV VAGLYPKPTL TAHPGPIMAP
241 GESLNLRCQG PIYGMTFALM RVEDLEKSFY HKKTIKNEAN FFFQSLKIQD TGHYLCFYYD
301 ASYRGSLLSD VLKIWVTDTF PKTWLLARPS AVVQMGQNVS LRCRGPVDGV GLALYKKGED
361 KPLQFLDATS IDDNTSFFLN NVTYSDTGIY SCHYLLTWKT SIRMPSHNTV ELMVVDKPPK
421 PSLSAWPSTV FKLGKAITLQ CRVSHPVLEF SLEWEERETF QKFSVNGDFI ISNVDGKGTG
481 TYSCSYRVET HPNIWSHRSE PLKLMGPAGY LTWNYVLNEA IRLSLIMQLV ALLLVVLWIR
541 WKCRRLRIRE AWLLGTAQGV TMLFIVTALL CCGLCNGVLI EETEIVMPTP KPELWAETNF
601 PLAPWKNLTL WCRSPSGSTK EFVLLKDGTG WIATRPASEQ VRAAFPLGAL TQSHTGSYHC
661 HSWEEMAVSE PSEALELVGT DILPKPVISA SPTIRGQELQ LRCKGWLAGM GFALYKEGEQ
721 EPVQQLGAVG REAFFTIQRM EDKDEGNYSC RTHTEKRPFK WSEPSEPLEL VIKEMYPKPF
781 FKTWASPVVT PGARVTFNCS TPHQHMSFIL YKDGSEIASS DRSWASPGAS AAHFLIISVG
841 IGDGGNYSCR YYDFSIWSEP SDPVELVVTE FYPKPTLLAQ PGPVVFPGKS VILRCQGTFQ
901 GMRFALLQEG AHVPLQFRSV SGNSADFLLH TVGAEDSGNY SCIYYETTMS NRGSYLSMPL
961 MIWVTDTFPK PWLFAEPSSV VPMGQNVTLW CRGPVHGVGY ILHKEGEATS MQLWGSTSND
1021 GAFPITNISG TSMGRYSCCY HPDWTSSIKI QPSNTLELLV TGLLPKPSLL AQPGPMVAPG
1081 ENMTLQCQGE LPDSTFVLLK EGAQEPLEQQ RPSGYRADFW MPAVRGEDSG IYSCVYYLDS
1141 TPFAASNHSD SLEIWVTDKP PKPSLSAWPS TMFKLGKDIT LQCRGPLPGV EFVLEHDGEE
1201 APQQFSEDGD FVINNVEGKG IGNYSCSYRL QAYPDIWSEP SDPLELVGAA GPVAQECTVG
1261 NIVRSSLIVV VVVALGVVLA IEWKKWPRLR TRGSETDGRD QTIALEECNQ EGEPGTPANS
1321 PSSTSQRISV ELPVPILocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGSF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 380 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 380 nTPM
- hypothalamus: 71 nTPM
- heart muscle: 32 nTPM
- midbrain: 32 nTPM
- basal ganglia: 28 nTPM
- testis: 18 nTPM
Single-cell type
- pituitary stem cells: 219 nCPM
- lactotrophs: 120 nCPM
- somatotrophs: 78 nCPM
- thyrotrophs: 62 nCPM
- adrenal medulla cells: 43 nCPM
- thymic myoid cells: 25 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 154 nTPM
- pons: 47 nTPM
- midbrain: 42 nTPM
- medulla oblongata: 22 nTPM
- thalamus: 20 nTPM
- basal ganglia: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IGSF1.
Disease | AllUniProt
Conditions IGSF1 is implicated in, by any mechanism.
- Hypothyroidism, central, and testicular enlargement (CHTE) MIM:300888
Disease | GeneticClinVar
29 pathogenic / likely-pathogenic of 485 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- X-linked central congenital hypothyroidism with late-onset testicular enlargement
- Inborn genetic diseases
- Thyroid cancer, nonmedullary, 1
- Pituitary hormone deficiency
- Paediatric disorders
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.21
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.15
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- immune response-regulating signaling pathway
- negative regulation of activin receptor signaling pathway
- regulation of DNA-templated transcription
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IGSF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGSF1 as an antibody target. Whether an autoantibody or antibody against IGSF1 could matter depends on whether native IGSF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGSF1 is annotated as secreted, so native IGSF1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IGSF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...